Meeting MET-Amplified NSCLC With Progress

Nicholas C. Rohs, MD, Isabel Preeshagul, DO, MBS, and Joshua K. Sabari, MD, discuss promising agents in the treatment of patients with non–small cell lung cancer with MET amplification.

The discussion was held during an episode of Thoracic Night Live.